Director/PDMR Shareholding

RNS Number : 4123I
Hill & Smith Hldgs PLC
08 August 2019
 

8 August 2019

Hill & Smith Holdings PLC

 

Director and PDMR Shareholdings

 

Notification under paragraphs 3.1.2R to 3.1.4R of the Disclosure and Transparency Rules

Hill & Smith Holdings PLC ('Hill & Smith' or the 'Company') announces that it has been notified that Mr Derek Muir, a Person Discharging Managerial Responsibilities of Hill & Smith has acquired 3,496 Ordinary Shares, awarded in July 2014 as employee share options, under the rules of the 2014 Employee ShareSave Scheme.

 

As a result, Derek Muir now has a beneficial interest in 366,982 Ordinary Shares and holds conditional performance LTIP awards and share options over 157,405 Ordinary Shares in the Company.

 

1.

Details of the Person Discharging Managerial Responsibilities/Person Closely Associated

(a)

Name

Mr D W Muir

2.

Reason for the notification

(a)

Position/status

Group Chief Executive

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith Holdings PLC

(b)

LEI

 2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Save As You Earn Scheme exercise

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

£4.29

3,496

(e)

Aggregated information

- Aggregated volume

- Price

 

3,496 shares

£4.29

(f)

Date of the transaction

7 August 2019

(g)

Place of the transaction

London Stock Exchange

 

Enquiries:

Alex Henderson

Company Secretary

Hill & Smith Holdings PLC

Tel: +44 (0) 121 704 7430


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFFATFITIIA
UK 100